Skip to content

Weaning From Mechanical Ventilation Guided by Lung Ultrasound (Brazilian WEANLUS)

Weaning From Mechanical Ventilation Guided by Lung Ultrasound (Brazilian WEANLUS)

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01966861
Acronym
WEANLUS-BR
Enrollment
300
Registered
2013-10-22
Start date
2016-03-31
Completion date
2019-05-31
Last updated
2018-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Keywords

mechanical ventilation, weaning, acute respiratory failure, weaning failure, lung ultrasound

Brief summary

The present study aims to evaluate the impact of a weaning strategy based on identification of early signs of respiratory distress by lung ultrasound and the consequent implementation of a clinical optimization protocol as compared to usual care.

Interventions

OTHERweaning guided by LUS (lung ultrasound)

Predictive early signs of respiratory distress are assessed by lung ultrasound (LUS score \>14) and if present will trigger protocolised intervention (eg- fluid balance,diuretics, thoracocentesis, antibiotics when required \[CPIS\>6\], hemglobin\>8g/dl triggers transfusion)

Sponsors

Hospital Sirio-Libanes
CollaboratorOTHER
University of Sao Paulo
CollaboratorOTHER
Hospital Israelita Albert Einstein
CollaboratorOTHER
D'Or Institute for Research and Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mechanically ventilated \>48h

Exclusion criteria

* Moderate/Severe COPD * Spinal cord lesion * Neuromuscular disease (previous) * Lung fibrosis * Tracheostomy * Heart failure (EF\<50%) * Lung/pleural cancer * inadequate windowfor LUS

Design outcomes

Primary

MeasureTime frame
Respiratory distress requiring re-intubation or non-invasive ventilation48hours

Secondary

MeasureTime frameDescription
28-day mortality28 days
Hospital MortalityHospital death/discharge (up to 60 days)
Adverse events48hRenal dysfunction, complications of thoracocentesis, hydro-electrolite changes, hypotension

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026